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Abstract
Background: Routine measurement of gastric residual volume (GRV) to guide feeding in neonatal and paediatric
intensive care is widespread. However, this practice is not evidence based and may cause harm. As part of a
feasibility study, we explored parent and practitioner views on the acceptability of a trial comparing GRV
measurement or no GRV measurement.
Methods: A mixed-methods study involving interviews and focus groups with practitioners and interviews with
parents with experience of tube feeding in neonatal and/or paediatric intensive care. A voting system recorded
closed question responses during practitioner data collection, enabling the collection of quantitative and qualitative
data. Data were analysed using thematic analysis and descriptive statistics.
Results: We interviewed 31 parents and nine practitioners and ran five practitioner focus groups (n=42).
Participants described how the research question was logical, and the intervention would not be invasive and
potential benefits of not withholding the child’s feeds. However, both groups held concerns about the potential
risk of not measuring GRV, including delayed diagnosis of infection and gut problems, increased risk of vomiting
into lungs and causing discomfort or pain. Parent’s views on GRV measurement and consent decision making were
influenced by their views on the importance of feeding in the ICU, their child’s prognosis and associated
comorbidities or complications.
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Conclusions: The majority of parents and practitioners viewed the proposed trial as acceptable. Potential concerns
and preferences were identified that will need careful consideration to inform the development of the proposed
trial protocol and staff training.
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Introduction
Critically ill neonates and children who receive sufficient
nutrition have reduced complications, spend less time on
mechanical ventilation, reduced time in intensive care and
have overall improved health outcomes [1–5]. Nutrition
should, if at all possible, be delivered enterally to maintain
gut barrier function [6]. On average, children in paediatric
intensive care units (PICUs) receive less than half of their
nutritional requirements [2, 7]. In preterm infants, feeds
are gradually increased to the immature, naïve gut and cli-
nicians closely observe feed tolerance and for signs of
complications such as necrotising enterocolitis [8].
One of the practices that contributes to children not re-
ceiving adequate enteral nutrition is the routine measure-
ment of the gastric residual volume (GRV) (fluid in the
stomach) to guide both the initiation and progression of
enteral feeds [9]. Commonly cited rationales for measur-
ing GRV are to assess ‘feed tolerance’, to prevent compli-
cations such as vomiting from a full stomach with
subsequent pulmonary aspiration and in neonates, to de-
tect necrotizing enterocolitis (NEC) [10]. Large GRVs al-
most always result in withholding or reducing of feed
volumes [11–13]. However, what is considered a ‘large’
GRV measurement and clinical response to this measure-
ment is extremely variable [14]. Importantly, this measure-
ment is not considered accurate [15–17] and has not been
shown to reflect delayed gastric emptying [18].
Clinical trials in the neonatal and paediatric critical care
setting are challenging to conduct due to ethical and prac-
tical considerations [19–22]. In line with the Medical Re-
search Council’s framework for complex intervention
development [23] conducting trial feasibility studies can
help mitigate these challenges and establish whether the
trial is acceptable to parents and practitioners, and prac-
tical to conduct [24, 25]. As part of a pre-trial feasibility
study [14, 26], we explored parent and practitioner per-
spectives on the acceptability of conducting a clinical trial
comparing no routine GRV measurement (the interven-
tion) to routine GRV measurement in UK neonatal inten-




A mixed-methods design involving interviews and focus
groups, incorporating a voting system to enable the
collection of both qualitative and quantitative data. Our
previous research, relevant literature and pre-study pa-
tient and public involvement guided the development of
the topic guides and participant information [27–29].
We explored parent and practitioner views on the ac-
ceptability of the proposed GASTRIC trial including ac-
ceptability of measuring or not measuring GRV,
willingness to participate in a future trial, trial informa-
tion materials, barriers and facilitators to trial recruit-
ment (S1, example parent topic guide).
Participant recruitment
Parent recruitment
Based on our previous studies [27, 29–31], we antici-
pated that 20–30 parents (n=10–15 in each setting)
would be needed to reach data and thematic saturation,
the point where additional data does not lead to any
new major themes during analysis and the researcher
notes high levels of ‘information redundancy’ during
data collection [32–34]. Parents of children with experi-
ence of tube feeding in NNU and/or PICU in the last 3
years were recruited through four routes: (1) social
media or website advertising [including Twitter (URL:
www.twitter.com; Twitter, Inc., San Francisco, CA,
USA), Bliss (URL: www.bliss.org.uk), Sepsis Trust (URL:
https://sepsistrust.org), hospital charities and Mumsnet
(URL: www.mumsnet.com)], (2) targeted emails to study
team contacts and a database from our previous research
[29], (3) an advert in a national newspaper and (4) word
of mouth (e.g. research team primary school networks).
Practitioner recruitment
We aimed to hold four focus groups (two NNU, two
PICU) in different geographical locations across the UK.
We also purposively targeted individuals and groups to
take part in a telephone interview to insure all key pro-
fessional groups were included (e.g. doctors, nurses, die-
titians and surgeons). We recruited through e-mail
invitations and postings on networks known to the co-
applicants of the study including the Paediatric Intensive
Care Society and British Dietetics Association.
Conduct of interviews and focus groups
Parent interviews
Psychologists LR and ED (PhD, female research associ-
ates) responded to parents’ requests to participate in
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sequential order, confirmed eligibility and emailed them
the draft trial participant information sheet (PIS) (S2,
PIS). A telephone or face-to-face interview was arranged
depending on geographical location and participant pref-
erence. There was no relationship between the re-
searcher and participant prior to the interviews. After
interviews participants were sent a £30 shopping vou-
cher to thank them for their time.
Practitioner focus groups and interviews
At the start of the focus group or interview, the re-
searcher (ED, LR) checked that participants had read the
PIS. Eleven closed questions were administered in focus
groups using a voting system (Turning Technologies,
Youngstown, OH, USA) and administered verbally dur-
ing interviews. This allowed for the collection of staff
demographic information, to insure data collection from
all staff on key questions and facilitate discussion. As
part of an iterative approach, we added or amended
questions in the parent and practitioner topic guides as
interviewing and analysis progressed (see S3, practitioner
topic guide) [35]. Audio-recorded verbal or written con-
sent was sought before interviews or focus groups began.
Interviews stopped when saturation point was reached.
All digital audio recordings were transcribed verbatim
by a professional transcription company (Voicescript
Ltd., Bristol, UK). Transcripts were anonymised and
checked for accuracy.
Data analysis
LR and ED led the qualitative analysis with assistance
from KW (PhD, sociologist). Analysis used a thematic
analysis approach [36–38] to examine patterns within
the data related to views on trial design and acceptability
(see S4, Table 1). Analysis was broadly interpretive, it-
erative and used a combination of inductive and deduct-
ive approaches to coding [39, 40]. NVivo 10 software
(QSR International Pty Ltd., Melbourne, Australia) was
used to assist in the organisation and coding of data.
Quantitative data from closed questions were entered
into SPSS Version 20.0 (IBM Corp., Armonk, NY, US).
Descriptive statistics are presented with frequencies and
percentages. Synthesis of qualitative and quantitative
data drew on the constant comparative method [41, 42].
This involved ED and LR looking across quantitative
and qualitative themes and quantitative output for
themes/data output related to trial acceptability. Analysis
was interpretive- theorising the significance of the pat-
terns and their broader meanings and implications. A
final stage of analysis involved consideration of both
qualitative and quantitative findings against the Theoret-
ical Framework of Acceptability (TFA) [25] to help con-
ceptualise and discuss the overall acceptability of the
proposed trial. The TFA is designed to assist researchers
in assessing the acceptability of healthcare interventions,
including clinical trials. The TFA presents seven theoret-
ical constructs for researchers to consider when asses-
sing whether people delivering or receiving a healthcare
intervention consider it to be appropriate.
Results
Participants—parents
Fifty-four parents registered interest, of whom 38 were
interviewed (Fig. 1). Two PICU parents were interviewed
but not included in the analysis due to recording equip-
ment failure. Saturation was reached both within and
across the NNU and PICU samples. Our final sample of
31 included 17 NNU and 14 PICU parents including 22
mothers (12 NNU, 10 PICU; 4 were bereaved) and nine
fathers (5 NNU, 4 PICU; 1 bereaved). Interviews took
place between May and November 2018. Seventeen
NNU parent interviews related to 19 children (Table 1)
and 21 different hospitals. Three mothers had twins who
were both admitted to NNU, and one set of parents
were interviewed separately regarding the same child.
Fourteen PICU parent interviews related to ten children,
with four sets of parents interviewed separately regard-
ing the same child. Six of the ten children had also been
admitted to NNU at birth and five had had multiple
PICU admissions. Interviews took place on average
(mode) 11 months (range=0.8–37 months) from hospital
admission and took on average 68 (SD=12.7) minutes.
Interviews took place between May and November 2018.
Participants—practitioners
Fifty-one practitioners took part in either a focus group or
interview. Five focus groups were conducted at three UK
hospitals, and this included two in NNU and three in
PICU. Forty-two practitioners (16 NNU, 26 PICU) partici-
pated in one of the five focus groups. Sixty-two percent
(26/42, 62%) of focus group participants were clinical
nurses. The remainder were research nurses (5/42, 12%),
senior doctors (3/42, 7%) and dietitians (2/42, 5%). Six
participants (6/42, 14%) categorised themselves as ‘other’.
Three were student nurses, three did not specify.
As the majority of focus group participants were nursing
staff, we purposively contacted ten consultant level doc-
tors’ doctors, three surgeons and five dietitians and invited
them to take part in a telephone interview. Five additional
dietitians expressed interest in being interviewed after re-
ceiving study information through their professional net-
works. Of those we directly targeted, 12/21 (58%) did not
respond. A total of nine interviews were conducted in-
cluding three consultant doctors (2 NNU, 1 PICU), four
dietitians (1 NNU, 3 PICU) and two surgeons (both sur-
geons worked with NNU and PICU patients).
Ten UK hospitals were represented in the combined
interview and focus group sample. The majority had
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experience of conducting paediatric clinical trials (39/51,
76%). Focus groups took on average 55 min (range 49–68
min) and telephone interviews 32 min (range 26–45 min).
Parents’ views on GRV measurement and feeding
Interviews began with a discussion of parents’ NNU/
PICU experience, including how they prioritised feeding
as a component of critical care and their knowledge of
GRV. Twenty-one parents (68%) recalled their child’s
GRV being measured (15 NNU, 6 PICU). Those who did
recall GRV being measured had varying understanding
of its utility:
I remember quite a few occasions where they were,
erm, sort of like take it out, work it out if there was too
much left then they wouldn’t do the next one as much.
(P21, Mother, PICU)
Fig. 1 Parent recruitment
Table 1 Child characteristics and NNU/PICU admission information based on parent interview accounts
Characteristics NNU PICU
Child age at hospital
admission (or birth)
Median 29 weeks of gestation
(range: 24–41 weeks)
Median 8-month old (range 3 weeks–12 years)
Days in unit Median 21 (range: 1–140,
missing n=1)
Median 8 (range 2–72)
Days in hospital Median 57 (range: 7–152) Median 39 (range 3–196)
Days on feeding tube Median 58 (range: 2–210) Median 127.5 (range: 5–547)
Days on breathing
support






Heart conditions, e.g. congenital heart defect, hyperplastic left heart (n=4)
Sepsis (n=2)
Reconstruction of airway (n=1) Complications linked to chronic conditions, e.g.
holoprosencephaly, Noonan’s syndrome, prematurity (n=3)
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Parent’s views around GRV measurement appeared to
be linked to their views on the importance of feeding in
the ICU, their child’s prognosis and associated comor-
bidities or complications. For example, parents of chil-
dren who experienced an imminently life-threating
condition, such as sepsis, had not considered feeding to
be a priority in the ICU:
Well initially obviously they were trying to keep her
alive (P24, mother, PICU).
In contrast, parents of premature children or those
with chronic conditions, such as a congenital heart de-
fect, viewed feeding as very important. Weight gain and
calorie intake were seen to have direct causal relation-
ship with short and longer-term outcomes:
We knew that gaining weight was central to them go-
ing home and we also knew that the greater their weight,
the less risk there was of an infection. (P05, father,
NNU)
Parents described how they were initially unaware of
how difficult, yet important, establishing feeds was at the
beginning of their NNU stay and would still be in what
feels like an acute situation:
I remember them saying, oh, they’ve coped really well
with the last feed, and you think, coped really well? How
hard is eating? And they don’t explain to you that it can
have a huge a huge impact (P11, mother, NNU).
Over half of the PICU parents had past NNU experi-
ence and therefore had already developed views on feed-
ing in the early phase of their PICU stay, which would
be the point at which parents would be approached to
discuss their child’s participation in the proposed trial.
Potential benefits and concerns about conducting the
proposed GASTRIC randomised control trial
Parents and practitioners were asked to consider the
proposed trial. Practitioners identified some potential
benefits of not measuring GRV such as reduced reliance
on intravenous lines and less problems with gut motility.
Both parents and practitioners described how not meas-
uring GRV might be beneficial because it might increase
nutritional intake and remove a potentially unnecessary
and “quite invasive” (P03, mother, NNU) intervention
that may increase the “risk of infection” (P03, FG3,
nurse, PICU). However, as Table 2 shows, 88% of practi-
tioners felt that there would be barriers to staff not
measuring GRV in the proposed trial.
Practitioners and parents voiced concerns about how
not measuring GRV may delay the diagnosis of bowel or
stomach problems, infection, NEC, or lead to incorrect
feeding tube placement or feed intolerance:
You’ll have a baby who you’re not measuring residuals
anymore, who will end up with NEC and then they’ll say
oh this would have been picked up earlier if we'd rea-
lised it has bilious aspects. (P05, FG5, consultant neonat-
ologist, NNU)
Nevertheless, half of the practitioner sample (mainly
doctors) interviewed also described how they:
Don’t think that measuring the GRV is going to be a,
um, reliable indicator of whether a baby’s got NEC or is
at risk of getting NEC (P05, interview, surgeon).
With others stating that measuring GRV was, on its
own: “completely meaningless” (P06, interview, doctor,
NNU) and that:
Babies who are gonna develop an important pathology,
never present purely with gastric residuals (P06, inter-
view, doctor, NNU).
Other concerns, such as not detecting incorrect tube
placement, or not being able to wind a child, were ad-
dressed by researcher clarification that children would
still have routine gastric aspirates assessed for tube pos-
ition (but not assessed for gastric residual volumes) in
line with existing guidance.
Parents and practitioners were also worried about the
risk of vomiting into the lungs leading to possible chest
infections and breathing difficulties. Interestingly, some
suggested contrasting views in that both measuring and
not measuring GRV may lead to vomiting or cause pain
and discomfort. Whilst some parents and practitioners
were concerned that returning stomach contents may
cause a child to vomit: “nine times out of ten if they shot
it back in she was sick.” (P15, NNU, father) or cause
pain or discomfort. Others felt that not measuring GRV
may result in discomfort and vomiting.
The challenge of changing routine clinical practice
Almost half the practitioners, unprompted, 23/51 (45%)
discussed the potential difficulty of changing such an ac-
cepted and embedded routine practice for a clinical trial:
I can imagine there will be barriers to it because it’s
just the way that things are done (P02, interview,
dietitian, PICU).
Nurses, in particular, valued GRV measurement as a
useful common practice that they perceived informed
patient care. Six participants, from a range of clinical
backgrounds, described how they would “feel uncom-
fortable” (P06, FG3, senior nurse, PICU) about changing
Table 2 Practitioner views on ‘Do you think there will be any barriers to staff not measuring GRV?’ in a proposed trial by role (N=48)
Senior nurse (n=11) Junior nurse (n=15) Research nurse (n=4) Senior doctor (n=7) Dietitian (n=7) Other (n=4) Total
Yes 9 (21%) 14 (33%) 4 (10%) 5 (12%) 6 (14%) 4 (10%) 42 (88)
No 2 (33%) 1 (17%) 0 (0%) 2 (33%) 1 (17%) 0 (0%) 6 (12)
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this ‘normal’ practice for a trial: “without the evidence”
(P07, FG2, research nurse, PICU) to support such a
change. Others stated that while they would personally
participate in the proposed trial, they felt that their col-
leagues may not be willing to change their behaviour:
If the surgeons are involved, they'll want to know what
aspirates are and the amount as well (P05, FG1, nurse,
NICU).
Some dietitians stated that they were planning to
change their practice to not measure GRV, which meant
the proposed trial was less of a concern to them. Sugges-
tions included the need for bespoke site training to assist
engagement and behaviour change, including additional
information to support the study rationale, including
evidence to:
Demonstrate why not measuring GRVs would be a
sensible thing to do and in fact might be beneficial (P05,
interview, surgeon).
Overall views on the acceptability of the proposed GAST
RIC randomised control trial
Parents and practitioners were asked to reflect and con-
sider the acceptability of the proposed trial. Despite the
concerns identified, the majority (39/46, 85%, 5 missing)
of practitioners indicated it would be acceptable ‘to con-
duct the proposed trial’. Only 15% (7/46) said it was not
acceptable to conduct. Of these seven, six were junior
nurses. Parents also supported the proposed trial, with
90% (28/31) stating that they would provide consent for
their child to take part. This acceptability was under-
pinned by a belief that the proposed study question:
‘makes perfect sense’ (P23, father, PICU). Overall, both
groups viewed the proposed ‘measuring GRV arm’ ac-
ceptable because it is a useful standard practice. For the
parents, hospitals would: ‘Just carrying on doing what
we’re doing anyway’ (P20, mother, PICU). There was
some ambivalence amongst clinical staff about the im-
portance of the proposed trial. Four doctors and one
surgeon reflected that GRV measurement was not a: ‘big
issue’ (P06, interview, doctor, NNU) or not important:
‘in the grand scheme of things’ (P07, interview, doctor,
PICU) (Table 3).
Parents with experience of tube feeding at the point of
their child’s intensive care admittance (n=11) appeared
to have a trial arm preference. However, the trial arm
(GRV or No GRV) they preferred varied. Although many
stated that their preference would not prevent them
from consenting to the trial, they would require detailed
information about the potential risks and benefits of
each trial arm to reach a consent decision. Conversely,
parents with no pre-existing knowledge or beliefs about
tube feeding viewed GRV measurement/no measure-
ment as of little importance. This view point was poten-
tially influenced by their view that feeding was a low
priority during a critical care situation. These parents
described how their child’s acute condition was the main
priority, and a trial involving measuring or not measur-
ing GRV would be therefore of low risk and therefore
acceptable.
I think that would be the last thing on me mind. So
no, it wouldn't bother me. (P27, mother, PICU & NNU).
Discussion
This study provides insight into the acceptability of the
proposed trial of no routine GRV measurement by ex-
ploring views of parent’s and practitioners with relevant
experience. Whilst studies have looked into parental
views of tube feeding in the home environment [43–46],
no previous research has explored parent or practitioner
views on feeding or GRV in in neonatal or children’s in-
tensive care. Overall, the majority of participants viewed
a trial of GRV measurement compared to no GRV in
NNU and/or PICU settings to be acceptable.
The Theoretical Model of Acceptability [25] provides
a framework to help researchers unpack the multifaceted
construct of acceptability, with seven components to
consider. Our data suggest that the GASTRIC trial met
five of the seven constructs [25]. The constructs of ‘op-
portunity costs’ and ‘self-efficacy’ were not fully met,
which both relate to changing behaviours to engage with
delivering the intervention. Parents and practitioners
were concerned about the risk of delayed diagnosis of
complications/problems by not measuring GRV, as well
as increased vomiting or pain. A key challenge is the
need for practitioners to change what is an accepted
routine practice. Nurses valued GRV measurement as a
useful practice that they perceived informed clinical de-
cision making. This practice may provide nurses with a
sense of security, in a practice-based profession where
‘doing things’ is highly valued [47]. Yet, the accuracy of
this practice is heavily criticised for providing inaccurate
values for a multitude of reasons. A previous study of
nurses’ decision-making around this practice [10]
showed most nurses frequently confused this practice
with that of aspirating a small amount of fluid to con-
firm correct feeding tube placement through pH meas-
urement. These concerns require careful consideration
and a targeted education package to help facilitate prac-
titioner engagement, particularly as some clinical staff
appeared to be ambivalent about the importance of the
proposed trial. Embedded research within the early
stages of a GASTRIC trial [29, 48] will help establish
whether this training is effective in assisting equipoise,
influencing perspectives and practitioner behaviour
change.
Parents’ views were often linked to their past experi-
ences of feeding in the ICU, their child’s prognosis, asso-
ciated comorbidities or complications and consequently
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duration of time on a feeding tube. This is particularly
important, as views on feeding and GRV appeared to in-
fluence parental decision-making about trial acceptabil-
ity. Therefore, in order to tailor trial discussions,
practitioners should firstly explore whether parents have
any previous ICU experience, the nature of the child’s
illness and information that may be prioritised in the
clinical setting.
The main limitation of this study is its hypothetical
nature. The findings related to the importance placed on
feeding, perceptions around measuring GRV and risk as-
sessment around medical factors were substantially in-
fluenced by experiential knowledge. This is knowledge
that the parents we interviewed had, but NNU parents
at the point of being approached about the proposed
GASTRIC trial may not. This is also true, but to a lesser
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existent, with the PICU parent sample who were more
likely to have past tube feeding experience.
The strengths of this study lie in its large sample, with
a range of views and experiences gathered from both
parent and practitioners across the UK, and from differ-
ent units with relevant experience. This insight enables
the development of a study protocol that can aim to ad-
dress potential challenges from the outset. In addition,
there is evidence to show that drawing on findings from
prospective acceptability studies’ to refine trial design
and practitioner training can have a substantial impact
on final acceptability [24, 29, 48].
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